Dominic B. Rowe

7.4k citations

84 papers · 3.9k indexed · 1 hit paper · h-index 30

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 34
- Parkinson's Disease Mechanisms and Treatments 31
- Neurological diseases and metabolism 12
- Neuroinflammation and Neurodegeneration Mechanisms 7
Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 34
- Parkinson's Disease Mechanisms and Treatments 31
- Neurological diseases and metabolism 12
- Neuroinflammation and Neurodegeneration Mechanisms 7
Biological Psychiatry top 2%
Cellular and Molecular Neuroscience top 2%
- Nuclear Receptors and Signaling 6
- Genetic Neurodegenerative Diseases 5
Sensory Systems top 5%
Genetics
- Neurogenetic and Muscular Disorders Research 20
Molecular Biology
- RNA regulation and disease 5

Co-authors: Glenda M. Halliday Carolyn Orr Stanley H. Appel Nicolas Dzamko Madelaine Ranola Irving OrtizYi HeYoshikuni Mizuno
Cited by: Neurology Biological Psychiatry
Partner nations: Australia United States United Kingdom

In The Last Decade

Dominic B. Rowe

77 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Peers

Countries citing papers authored by Dominic B. Rowe

Since Specialization

Citations

This map shows the geographic impact of Dominic B. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominic B. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominic B. Rowe more than expected).

Fields of papers citing papers by Dominic B. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominic B. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominic B. Rowe. The network helps show where Dominic B. Rowe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dominic B. Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dominic B. Rowe Line = papers co-authored together Dominic B. Rowe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement Natalie Grima,Andrew Smith,Claire E. Shepherd,Lyndal Henden,Thiri Zaw,Luke Carroll,Dominic B. Rowe,Matthew C. Kiernan,Ian P. Blair,Kelly L. Williams	2025	0
2	Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study Florin Gandor,Luise Berger,Vera D. Jäger,Katharina Demmin,Doreen Gruber,Katja Schimming,Paulina Thimm,Georg Ebersbach,Stefanie Schreiber,Dominic B. Rowe,Adam P. Vogel	2025	0
3	C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD Jessica Sultana,Audrey Ragagnin,Sonam Parakh,Sayanthooran Saravanabavan,Kai Y. Soo,Marta Vidal,Cyril J. Jagaraj,Kunjie Ding,Sharlynn Wu,Sina Shadfar,Emily K. Don,Anand K. Deva,Garth A. Nicholson,Dominic B. Rowe,Ian P. Blair,Shu Yang,Julie D. Atkin	2024	4
4	Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry Lyndal Henden,Liam G. Fearnley,Dean Southwood,Andrew Smith,Dominic B. Rowe,Matthew C. Kiernan,Roger Pamphlett,Melanie Bahlo,Ian P. Blair,Kelly L. Williams	2024	0
5	Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS Yue Yang,Dominic B. Rowe,Heather McCann,Claire E. Shepherd,Jillian J. Kril,Matthew C. Kiernan,Glenda M. Halliday,Rachel H. Tan	2023	13
6	Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia Katherine Phan,Ying He,YuHong Fu,Nicolas Dzamko,Surabhi Bhatia,Julian Gold,Dominic B. Rowe,Yazi D. Ke,Lars M. Ittner,John R. Hodges,Olivier Piguet,Matthew C. Kiernan,Glenda M. Halliday,Woojin S. Kim	2021	22
7	Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-l-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis Michael S. Bereman,Kaylie I. Kirkwood‐Donelson,Tharani Sabaretnam,Sarah Furlong,Dominic B. Rowe,Gilles J. Guillemin,Allyson L. Mellinger,David C. Muddiman	2020	17
8	Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression Ingrid Tarr,Emily P. McCann,Beben Benyamin,Timothy J. Peters,Natalie A. Twine,Katharine Y. Zhang,Qiongyi Zhao,Zong Hong Zhang,Dominic B. Rowe,Garth A. Nicholson,Denis C. Bauer,Susan J. Clark,Ian P. Blair,Kelly L. Williams	2019	30
9	Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort Paul Talman,Thi Duong,Steve Vucic,Susan Mathers,Svetha Venkatesh,Robert D. Henderson,Dominic B. Rowe,David Schultz,R H Edis,Merrilee Needham,Richard Macdonnell,Pamela McCombe,Carol Birks,Matthew C. Kiernan	2016	48
10	Predicting a Positive Response to Intravenous Immunoglobulin in Isolated Lower Motor Neuron Syndromes James R. Burrell,Con Yiannikas,Dominic B. Rowe,Matthew C. Kiernan	2011	12
11	Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers Steve Vucic,Jennica M. Winhammar,Dominic B. Rowe,Matthew C. Kiernan	2010	18
12	The phase shift index for marking functional asynchrony in Alzheimer's disease patients using fMRI Yin Xu,Guofan Xu,Gaohong Wu,Piero Antuono,Dominic B. Rowe,Shi‐Jiang Li	2008	17
13	Signal and noise of Fourier reconstructed fMRI data Dominic B. Rowe,Andrew S. Nencka,Raymond G. Hoffmann	2006	18
14	Anticipation of onset age in familial Parkinson's disease without SCA gene mutations Yue Huang,Mike Hayes,Antony J. Harding,William S. Brooks,Victor S.C. Fung,Dominic B. Rowe,R Joffe,Denis Crimmins,M. A. Hely,Glenda M. Halliday	2006	3
15	Assessment of disease progression in motor neuron disease Jennica M. Winhammar,Dominic B. Rowe,Robert D. Henderson,Matthew C. Kiernan	2005	63
16	Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells Jie Li,Carsten Scheller,Eleni Koutsilieri,Francine M. Griffiths,Philip M. Beart,Linda D. Mercer,Glenda M. Halliday,Emma Kettle,Dominic B. Rowe,Peter Riederer,Manfred Gerlach,Michael Rodriguez,Kay L. Double	2005	25
17	Immune-inflammatory changes in the substantia nigra in Parkinson's disease Carolyn Orr,Dominic B. Rowe,Glenda M. Halliday	2004	0
18	Isolated fascicular oculomotor nerve palsy as the initial presentation of the antiphospholipid syndrome Bernard Champion,Fiona Choy,Leslie Schrieber,James Roche,Dominic B. Rowe	2002	10
19	Complications from intra-aortic balloon counterpulsation: a review of 303 cardiac surgical patients J. Álvarez,R. N. Gates,Dominic B. Rowe,Patrick Brady	1992	30
20	Breakdown and quantitation of the forked termination of replication intermediate of Bacillus subtilis Peter J. Hanley,C.M. Carrigan,Dominic B. Rowe,R.G. Wake	1987	11

About Dominic B. Rowe

Dominic B. Rowe is a scholar working on Neurology, Neurology and Genetics, having authored 84 papers that have together received 3.9k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (34 papers), Parkinson's Disease Mechanisms and Treatments (31 papers), Neurogenetic and Muscular Disorders Research (20 papers), Neurological diseases and metabolism (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Nuclear Receptors and Signaling (6 papers), Genetic Neurodegenerative Diseases (5 papers) and RNA regulation and disease (5 papers). The work is most often cited by research in Neurology (1.3k citations), Neurology (1.8k citations) and Biological Psychiatry (179 citations). Dominic B. Rowe has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Glenda M. Halliday, Carolyn Orr, Stanley H. Appel, Nicolas Dzamko, Madelaine Ranola, Irving Ortiz, Yi He, Yoshikuni Mizuno, Hideo Mori and Wenjie Xie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact